Copeptin predicts clinical deterioration and persistent instability in community-acquired pneumonia

Respiratory Medicine

Volumn 106, Issue 9, 2012, Pages 1320-1328

  Kolditz, M ^a   Halank, M ^a   Schulte Hubbert, B ^a   Bergmann, S ^a   Albrecht, S ^a   Hoffken G ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Biomarker; Community acquired pneumonia; ICU admission; Risk stratification

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; COPEPTIN; PROADRENOMEDULLIN; PROCALCITONIN;

ADULT; AGED; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; FEMALE; HIGH RISK PATIENT; HORMONE BLOOD LEVEL; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE UNIT; KAPLAN MEIER METHOD; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT IDENTIFICATION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COMMUNITY-ACQUIRED INFECTIONS; DISEASE PROGRESSION; FEMALE; GLYCOPEPTIDES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; ROC CURVE;

EID: 84864609839     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2012.06.008     Document Type: Article

References (30)

1. M.J. Fine, T.E. Auble, D.M. Yealy, B.H. Hanusa, L.A. Weissfeld, and D.E. Singer A prediction rule to identify low-risk patients with community-acquired pneumonia N Engl J Med 336 1997 243 250 (Pubitemid 27044625)
2. T.T. Bauer, S. Ewig, R. Marre, N. Suttorp, and T. Welte CRB-65 predicts death from community-acquired pneumonia J Intern Med 260 2006 93 101 (Pubitemid 43894075)
3. Y.K. Loke, C.S. Kwok, A. Niruban, and P.K. Myint Value of severity scales in predicting mortality from community-acquired pneumonia: systematic review and meta-analysis Thorax 65 2010 884 890
4. J.D. Chalmers, A. Singanayagam, A.R. Akram, P. Mandal, P.M. Short, and G. Choudhury Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis Thorax 65 2010 878 883
5. J.D. Chalmers, P. Mandal, A. Singanayagam, A.R. Akram, G. Choudhury, P.M. Short, and A.T. Hill Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysis Intensive Care Med 37 2011 1409 1420
6. L.A. Mandell, R.G. Wunderink, A. Anzueto, J.G. Bartlett, G.D. Campbell, and N.C. Dean Infectious Diseases Society of America/American Thoracic Society Consensus guidelines on the management of community-acquired pneumonia in adults Clin Infect Dis 44 2007 S27 S72
7. A. Liapikou, M. Ferrer, E. Polverino, V. Balasso, M. Esperatti, and R. Piner Severe community-acquired pneumonia: validation of the Infectious Diseases Society of America/American Thoracic Society guidelines to predict an intensive care unit admission Clin Infect Dis 48 2009 377 385
8. M.I. Restrepo, E.M. Mortensen, J. Rello, J. Brody, and A. Anzueto Late admission to the ICU in patients with community-acquired pneumonia is associated with higher mortality Chest 137 2010 552 557
9. B. Renaud, A. Santin, E. Coma, N. Camus, D. Van Pelt, and J. Hayon Association between timing of intensive care unit admission and outcomes for emergency department patients with community-acquired pneumonia Crit Care Med 37 2009 2867 2874
10. S. Ewig, M. Woodhead, and A. Torres Towards a sensible comprehension of severe community-acquired pneumonia Intensive Care Med 37 2011 214 223
11. S. Krüger, S. Ewig, R. Marre, J. Papassotiriou, K. Richter, and H. von Baum Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes Eur Respir J 31 2008 349 355
12. P.E. Charles, C. Tinel, S. Barbar, S. Aho, S. Prin, and J.M. Doise Procalcitonin kinetics within the first days of sepsis: relationship with the appropriateness of antibiotic therapy and the outcome Crit Care 13 2009 R38
13. M. Christ-Crain, D. Stolz, R. Bingisser, C. Muller, D. Miedinger, and P.R. Huber Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial Am J Respir Crit Care Med 174 2006 84 93 (Pubitemid 43955248)
14. S. Krüger, S. Ewig, J. Kunde, O. Hartmann, N. Suttorp, and T. Welte Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ Thorax 65 2010 208 214
15. S. Krüger, S. Ewig, S. Giersdorf, O. Hartmann, N. Suttorp, and T. Welte Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ Am J Respir Crit Care Med 182 2010 1426 1434
16. P. Schuetz, M. Wolbers, M. Christ-Crain, R. Thomann, C. Falconnier, and I. Widmer Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections Crit Care 14 2010 R106
17. R. Menéndez, R. Martinez, S. Reyes, J. Mensa, E. Polverino, and X. Filella Stability in community-acquired pneumonia: one step forward with markers? Thorax 64 2009 987 992
18. S. Aliberti, A. Amir, P. Peyrani, M. Mirsaeidi, M. Allen, and B.K. Moffett Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia Chest 134 2008 955 962
19. S. Ewig, N. Birkner, R. Strauss, E. Schaefer, J. Pauletzki, and H. Bischoff New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality Thorax 64 2009 1062 1069
20. N.G. Morgenthaler, J. Struck, C. Alonso, and A. Bergmann Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin Clin Chem 52 2006 112 119 (Pubitemid 43032474)
21. G. Höffken, J. Lorenz, W. Kern, T. Welte, T. Bauer, and K. Dalhoff Epidemiology, diagnosis, antimicrobial therapy and management of community-acquired pneumonia and lower respiratory tract infections in adults. Guidelines of the Paul-Ehrlich-Society for Chemotherapy, the German Respiratory Society, the German Society for Infectiology and the Competence Network CAPNETZ Germany Pneumologie 63 2009 e1-68
22. E.A. Halm, M.J. Fine, T.J. Marrie, C.M. Coley, W.N. Kapoor, D.S. Obrosky, and D.E. Singer Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines JAMA 279 1998 1452 1457 (Pubitemid 28228202)
23. J.A. Hanley, and B.J. McNeil A method of comparing the areas under receiver operating characteristic curves derived from the same cases Radiology 148 1983 839 843 (Pubitemid 13033817)
24. N.G. Morgenthaler Copeptin: a biomarker of cardiovascular and renal function Congest Heart Fail 16 Suppl. 1 2010 S37 S44
25. N.G. Morgenthaler, B. Müller, J. Struck, A. Bergmann, H. Redl, and M. Christ-Crain Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock Shock 28 2007 219 226 (Pubitemid 47220835)
26. S. Aliberti, P. Peyrani, G. Filardo, M. Mirsaeidi, A. Amir, F. Blasi, and J.A. Ramirez Association between time to clinical stability and outcomes after discharge in hospitalized patients with community-acquired pneumonia Chest 140 2011 482 488
27. J.A. Ramirez, L. Srinath, S. Ahkee, A. Huang, and M.J. Raff Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia Arch Intern Med 155 1995 1273 1276
28. V.F. Corrales-Medina, K.N. Suh, G. Rose, J.A. Chirinos, S. Doucette, D.W. Cameron, and D.A. Fergusson Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies PLoS Med 8 2011 e1001048
29. P. Schuetz, I. Suter-Widmer, A. Chaudri, M. Christ-Crain, W. Zimmerli, and B. Mueller Prognostic value of procalcitonin in community-acquired pneumonia Eur Respir J 37 2011 384 392
30. W.C. Albrich, F. Dusemund, K. Rüegger, M. Christ-Crain, W. Zimmerli, and T. Bregenzer Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm BMC Infect Dis 11 2011 112